PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance. (ANI) New Delhi [India], ...

Aurora Pharmaceutical logo "Our sales team is the backbone of our customer relationships, and this expansion reflects both our business growth and our dedication to providing best-in-class service to ...

Tel Aviv [Israel], February 2 (ANI/TPS): Shareholders of the Israeli bio-pharmaceutical startup, Kadimastem Ltd. approved the company's merger with the Swiss bio-pharmaceutical company NLS Limited on ...

Is ANI Pharmaceuticals (ANIP) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

ANI Pharmaceuticals had a positive return on equity of 15.87% and a negative net margin of 1.28%. The firm had revenue of $148.30 million during the quarter, compared to analyst estimates of $144. ...